The FDA has recalled a blood pressure medication nationwide, classifying it as Class II in an updated recall. Additionally, Mezzetta has recalled 32-ounce jars of Golden Greek Peperoncini from lot 720106 due to a social media video showing possible pest contamination. The FDA has also increased enforcement actions against imported food products adulterated for economic gain.
More Top Stories
Rod Stewart to Go on Final Tour in 2027
Sir Rod Stewart has officially announced his final tour, referred to as 'The Final Encore', for 2027. This wil...
India's triumph over WI in a thrilling ODI match
India decided to bowl first following their toss victory. Naman Dhir entered the ODI stage. The match was held...
Sedriques Dumas clashed with Luis Hernandez at UFC Vegas 121
Sedriques Dumas took on Luis Hernandez in Vegas. Hernandez had a notable weight advantage. The match was part...
Dennis Haskins, recognized for his role in 'Saved by the Bell', has passed away at 75.
Dennis Haskins, recognized for his roles in 'Saved by the Bell' and 'Z! True Long Island Story', has died at t...
Xbox gaming division restructured by Microsoft
Microsoft has reorganized its Xbox gaming division following 268 new layoffs. Halo HQ staff now log on from th...
The Philadelphia Eagles and Chicago Bears face off in Week 3
The Philadelphia Eagles will face the Chicago Bears in Week 3 of the 2026 NFL season. The game is scheduled fo...
News Roundup · Latest Update · Weekly Review · Daily Digest · Latest Update · Daily Digest · Daily Digest · Latest Update · Weekly Review · Daily Digest · Local Briefing · Weekly Review · Local Briefing · Local Briefing · Local Briefing · Local Briefing · News Roundup · Local Briefing · Daily Digest · Latest Update · Local Briefing · Daily Digest · Community Report · Community Report · Latest Update · Local Briefing · Latest Update · Latest Update · Daily Digest · Weekly Review · Community Report · Community Report · Daily Digest · News Roundup · Community Report · Local Briefing · News Roundup · Local Briefing · Local Briefing · Weekly Review